Lead Discovery Center GmbH - Product Pipeline Review - 2014

Published: Nov, 2014 | Pages: 60 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Lead Discovery Center GmbH - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Lead Discovery Center GmbH - Product Pipeline Review - 2014', provides an overview of the Lead Discovery Center GmbH's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Lead Discovery Center GmbH's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Lead Discovery Center GmbH including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Lead Discovery Center GmbH's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Lead Discovery Center GmbH's pipeline products

Reasons to buy

- Evaluate Lead Discovery Center GmbH's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Lead Discovery Center GmbH in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Lead Discovery Center GmbH's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Lead Discovery Center GmbH and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Lead Discovery Center GmbH
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Lead Discovery Center GmbH and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 6
Lead Discovery Center GmbH Snapshot 7
Lead Discovery Center GmbH Overview 7
Key Information 7
Key Facts 7
Lead Discovery Center GmbH - Research and Development Overview 8
Key Therapeutic Areas 8
Lead Discovery Center GmbH - Pipeline Review 12
Pipeline Products by Stage of Development 12
Pipeline Products - Monotherapy 13
Pipeline Products - Partnered Products 14
Partnered Products/Combination Treatment Modalities 15
Pipeline Products - Out-Licensed Products 16
Out-Licensed Products/Combination Treatment Modalities 17
Lead Discovery Center GmbH - Pipeline Products Glance 18
Lead Discovery Center GmbH - Early Stage Pipeline Products 18
Preclinical Products/Combination Treatment Modalities 18
Discovery Products/Combination Treatment Modalities 19
Lead Discovery Center GmbH - Drug Profiles 21
LDC-2636 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
LDC-4297 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Small Molecules for Oncology 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Small Molecule 1 For Cancer 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Small Molecule 2 for Cancer 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Small Molecule for Amyotrophic Lateral Sclerosis 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Small Molecule for Cancer 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Small Molecule for Cancer, Inflammation and AMD 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Small Molecule to Activate TRIM32 for Neurodegenerative Disease 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Small Molecule to Inhibit AML1/ETO for Acute Myeloid Leukemia 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Small Molecule to Inhibit Chemerin for Inflammation 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Small Molecule to Inhibit degS Serine Endoprotease for Bacterial Infections 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Small Molecule to Inhibit HIF1A for Cancer and Metabolic Syndrome 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Small Molecule to Inhibit Immunoproteasome Subunit LMP7 for Autoimmune Disorder and Viral Infections 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Small Molecule to Inhibit LRRK2 for Parkinson's Disease 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
Small Molecule to Inhibit SFRP1 for Cancer 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
Small Molecule to Target FKBP51 for Major Depressive Disorder 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
Small Molecule to Target Hedgehog Pathway for Oncology 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
Small Molecule to Target K-Ras/PDE Delta for Cancer 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
Small Molecule to Target MARK2 for Alzheimer's Disease 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
Small Molecule to Target Nrg1-ErbB4 Pathway for Schizophrenia 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
Small Molecule to Target Plexin-B1/Sema4D for Multiple Sclerosis and Osteoporosis 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
Small Molecule to Target Rab-1 for Solid Tumors 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
Small Molecule to Target SLC6A15 for Major Depressive Disorder 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
Small Molecule-3 for Cancer 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
Small Molecules for Atherosclerosis and Obesity 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
Small Molecules for Cancer 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
Small Molecules for Influenza 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
Small Molecules for Lung Cancer 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
Small Molecules to Activate SIRT for Metabolic Syndrome and Cardiovacular Diseases 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
Small Molecules to Inhibit Cyclin-Dependent Kinase 7 for Oncology, Immunology and Infectious Diseases 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
Small Molecules to Inhibit Cyclophilin for Immunology and Respiratory Disorders 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
Small Molecules to Inhibit NET Formation for Sepsis and SLE 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
Small Molecules to Target Notch Signaling Pathway for Oncology 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
Lead Discovery Center GmbH - Pipeline Analysis 55
Lead Discovery Center GmbH - Pipeline Products by Target 55
Lead Discovery Center GmbH - Pipeline Products by Molecule Type 56
Lead Discovery Center GmbH - Pipeline Products by Mechanism of Action 57
Lead Discovery Center GmbH - Locations And Subsidiaries 58
Head Office 58
Appendix 59
Methodology 59
Coverage 59
Secondary Research 59
Primary Research 59
Expert Panel Validation 59
Contact Us 60
Disclaimer 60

List of Tables
Lead Discovery Center GmbH, Key Information 7
Lead Discovery Center GmbH, Key Facts 7
Lead Discovery Center GmbH - Pipeline by Indication, 2014 10
Lead Discovery Center GmbH - Pipeline by Stage of Development, 2014 12
Lead Discovery Center GmbH - Monotherapy Products in Pipeline, 2014 13
Lead Discovery Center GmbH - Partnered Products in Pipeline, 2014 14
Lead Discovery Center GmbH - Partnered Products/ Combination Treatment Modalities, 2014 15
Lead Discovery Center GmbH - Out-Licensed Products in Pipeline, 2014 16
Lead Discovery Center GmbH - Out-Licensed Products/ Combination Treatment Modalities, 2014 17
Lead Discovery Center GmbH - Preclinical, 2014 18
Lead Discovery Center GmbH - Discovery, 2014 19
Lead Discovery Center GmbH - Pipeline by Target, 2014 55
Lead Discovery Center GmbH - Pipeline by Molecule Type, 2014 56
Lead Discovery Center GmbH - Pipeline Products by Mechanism of Action, 2014 57